[Effect of JQ1 on expression of autoimmune-related genes in CD4+T cells of systemic lupus erythematosus]

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Jul 28;43(7):704-710. doi: 10.11817/j.issn.1672-7347.2018.07.002.
[Article in Chinese]

Abstract

To investigate the effect of bromodomain and extra-terminal (BET) protein inhibitor JQ1 on expression of autoimmune-related genes in CD4+T cells from patients with systemic lupus erythematosus (SLE). Methods: Peripheral CD4+T cells were isolated by positive selection with CD4 microbeads. The percentage of CD4+T cells were detected by flow cytometry. CD4+T cells were treated by JQ1 at 100 nm/L for 6, 24, 48 h. The expression of T cell-related genes was measured by quantitative real-time PCR (qPCR). The secretion levels of cytokines in culture supernatant were measured by ELISA at 48 h. Results: The percentage of CD4+T cells isolated by CD4 microbeads is 97.2%. Compared with the control group, the mRNA expression levels of IFNG, IL-17F, IL-21, CXCR5 and FOXP3 were down-regulated at 6, 24 and 48 h (P<0.05), and IL-17A mRNA level was decreased at 6 and 24 h (P<0.01); while IL-4 mRNA level was up-regulated at 24, 48 h (P<0.01), and TGF-β1 mRNA level was up-regulated at 6 and 48 h (P<0.05) in SLE CD4+T cells treated with JQ1. The secretion levels of IFN-γ and IL-21 in JQ1-treated group were decreased significantly (P<0.05), while the secretion levels of IL-4 and TGF-β were up-regulated compared with control group (P<0.05). Conclusion: JQ1 can reverse the immune dysregulation and improve the immunity homeostasis in CD4+T cells from patients with SLE.

目的:探讨溴结构域(bromodomain and extra-terminal,BET)蛋白抑制剂JQ1对系统性红斑狼疮(systemic lupus erythematosus,SLE)外周血CD4+T细胞中自身免疫相关基因表达的作用。方法:利用磁珠分选获得SLE患者CD4+T细胞,采用流式细胞检测CD4+T细胞纯度。用JQ1(100 nm/L)处理CD4+T细胞6,24,48 h后收集细胞。采用实时荧光定量PCR(quantitative real-time PCR,qPCR)检测不同辅助性T细胞亚类特异性基因的mRNA表达。采用ELISA法检测细胞培养上清中细胞因子的蛋白水平。结果:磁珠分选所得CD4+T细胞百分比为97.2%。与对照组相比,JQ1处理组IFNG,IL-17F,IL-21,CXCR5和FOXP3 mRNA表达水平在6,24,48 h均显著降低(P<0.05),IL-17A mRNA表达在6,24 h显著下降(P<0.01),IL-4 mRNA表达在24,48 h显著升高(P<0.01),TGF-β1 mRNA表达在6,48 h显著升高(P<0.05)。JQ1处理48 h细胞培养上清中IFN-γ,IL-21和IL-17蛋白水平明显下降(P<0.05),IL-4和TGF-β蛋白水平明显升高(P<0.05)。结论:BET蛋白抑制剂JQ1可纠正SLE患者CD4+T细胞中的免疫调节失衡,促进免疫稳态恢复。.

MeSH terms

  • Azepines / pharmacology*
  • CD4 Lymphocyte Count
  • CD4-Positive T-Lymphocytes / cytology
  • CD4-Positive T-Lymphocytes / drug effects*
  • CD4-Positive T-Lymphocytes / metabolism
  • Cytokines / analysis
  • Cytokines / metabolism*
  • Flow Cytometry
  • Humans
  • Interferon-gamma / metabolism
  • Lupus Erythematosus, Systemic / immunology*
  • Lupus Erythematosus, Systemic / metabolism
  • Proteins / antagonists & inhibitors*
  • RNA, Messenger / metabolism
  • Time Factors
  • Transforming Growth Factor beta1
  • Triazoles / pharmacology*

Substances

  • (+)-JQ1 compound
  • Azepines
  • Cytokines
  • Proteins
  • RNA, Messenger
  • Transforming Growth Factor beta1
  • Triazoles
  • bromodomain and extra-terminal domain protein, human
  • Interferon-gamma